Initial Consultation

Service Description

Enable Genomics is a group purchasing organization with a unique set of business skills to help its members with a cost-benefit analysis of incorporating advanced molecular diagnostics (Next-Gen Sequencing, Pharmacogenomic) into their business and clinical workflow. Through the discovery process, Enable Genomics will help its members understand relevant payer policies, along with clinically meaningful assays and platforms that will meet their current and future genomic needs. During this initial consultation, the member practice will state its strategic goals for incorporating advanced molecular diagnostics. Enable Genomics will provide an overarching view of trends in the community oncology space for incorporating molecular testing into practice workflow.